This document provides financial and stock performance data for a company over several years on a quarterly and annual basis. It includes metrics like sales, operating profit, net income, debt ratios, and stock prices. It also evaluates the company's current stock price compared to an indication price range and assigns a probability score for the stock price rising. The document recommends a purchase amount for the stock based on the analysis.

1. Performance Analysis of Algorithm (consolidated) 063160 Date
Period 3 months 100-m won
2017.12 2018.12 2019.12 Average 2020.03 2020.06 2020.09 2020.12 2021.03 2021.06
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 1,182 1,245 1,372 1,266 304 347 327 268 259 251 312
O-profit 90 70 154 105 34 39 13 -11 -20 -35 19
N-income 80 80 123 94 25 34 14 -10 -16 -27 16
O-rate 7.6 5.6 11.2 8.2 11.2 11.2 4.0 -4.1 -7.6 -14.0 5.6
N-rate 6.8 6.4 9.0 7.4 8.2 9.8 4.3 -3.7 -6.4 -10.8 4.6
ROE 5.6 5.4 7.8 6.3 6.3 7.3 5.6 4.2 3.9 3.5 5.8
Debt-ratio 26.3 25.0 47.3 32.9 57.2 63.6 69.3 68.0 72.2 76.6 64.5
Quick-ratio 190.3 211.4 108.2 170.0 92.2 81.9 76.9 63.6 67.9 102.3 78.6
reserve-ratio 996.9 1,042.7 1,125.2 1,055.0 1,081.8 1,105.8 1,136.5 1,134.3 1,152.9 1,171.8 1,114.6
EPS 1,458 1,458 2,242 1,720 456 620 255 -182 -300 -495 287
BPS 25,884 26,923 28,892 27,233 29,129 29,749 30,806 30,751 31,315 31,890 30,109
Dividends 381 190 190 254
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
2021-05-12
Gap
(Indication /
stock)
Color
High price ~ -27 %
High mid ~ -36 %
Mid ~ -45 %
Low mid ~ -55 %
Low price ~ -64 %
Sell
24,360 W 24,360 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 39 3,125 992
42,909 W 42,909 W 36,726 W
36,726 W 36,726 W 30,543 W Evaluation
49,092 W 49,092 W~ 42,909 W
67,300 W
37.3
30,543 W 30,543 W 24,360 W
High price
Indication price Range Current stock price Company score
24,360원
30,543원
36,726원
42,909원
49,092원
High price 67,300원
-64%
-55%
-45%
-36%
-27%
-70%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
0W
10,000W
20,000W
30,000W
40,000W
50,000W
60,000W
70,000W
80,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
chong kun dang bio
Gap
chong kun dang bio

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 063160 Date
Period
Gap
(Indication /
stock)
Color
low price 24,360 W 24,360 W ~ 0 W -64 % 178,518 W 7
Low mid 30,543 W 30,543 W ~ 24,360 W -55 % 152,812 W 5
Mid 36,726 W 36,726 W ~ 30,543 W -45 % 127,106 W 3
High mid 42,909 W 42,909 W ~ 36,726 W -36 % 101,400 W 2
Suggested Purchase
Amount 279,788 W
Number of stocks
purchased 4
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 49,092 W 49,092 W~ ~ 42,909 W -27 % 75,695 W 2
2021-05-12
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
67,300 W High price 30.6 Sell 1,500,000 W
45.1 39.7 37.0 11.7 35.6 42.8
2020.12.11 2021.01.13 2021.02.10 2021.03.15 2021.04.12 2021.05.11
Stock price rise
probability score
A Sector 45.6 43.1 54.8 51.2 49.0 49.3
30.6
B Sector 44.6 36.3 19.2 51.2 22.1 36.3
Total average
2021.02.10 2021.03.15 2021.04.12 2021.05.11
Total of
increase rate
Total score
A Sector -6 % 21 % -7 % -4 % 1 %
-31 % 45.0
B Sector -23 % -89 % 63 % -132 % 39 %
Total average -14 % -7 % -217 % 67 % 17 %
2021.01.13
46 43
55
51 49 49
45
36
19
51
22
36
45
40
37
12
36
43
0
10
20
30
40
50
60
2020.12.11 2021.01.13 2021.02.10 2021.03.15 2021.04.12 2021.05.11
Stock price rise probability score
A sector
B sector
Total average
-6%
21%
-7% -4% 1%
-23%
-89%
63%
-132%
39%
-14% -7%
-217%
67%
17%
-250%
-200%
-150%
-100%
-50%
0%
50%
100%
2021.01.13 2021.02.10 2021.03.15 2021.04.12 2021.05.11
Increase rate of stock price rise
A sector
B sector
Total average
chong kun dang bio

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report